Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

592 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Transferring care to enhance access to early-phase cancer clinical trials: Protocol to evaluate a novel program.
Nwachukwu C, Makhnoon S, Person M, Muthukrishnan M, Kazmi S, Anderson LD, Kaur G, Kapinos KA, Williams EL, Fatunde O, Sadeghi N, Robles F, Basey A, Hulsey T, Pruitt SL, Gerber DE. Nwachukwu C, et al. Among authors: kazmi s. Contemp Clin Trials Commun. 2024 Apr 8;39:101292. doi: 10.1016/j.conctc.2024.101292. eCollection 2024 Jun. Contemp Clin Trials Commun. 2024. PMID: 38623454 Free PMC article.
Disparities in Characteristics, Access to Care, and Oncologic Outcomes in Young-Onset Colorectal Cancer at a Safety-Net Hospital.
Fangman BD, Goksu SY, Chowattukunnel N, Beg MS, Sanford NN, Sanjeevaiah A, Cox J, Folkert MR, Aguilera TA, Mathews J, Pogacnik JS, Khatri G, Olson C, Polanco PM, Verma U, Hsiehchen D, Jones A, Kainthla R, Kazmi SM. Fangman BD, et al. Among authors: kazmi sm. JCO Oncol Pract. 2021 May;17(5):e614-e622. doi: 10.1200/OP.20.00777. Epub 2021 Jan 11. JCO Oncol Pract. 2021. PMID: 33428470 Free PMC article.
The phosphatidylserine targeting antibody bavituximab plus pembrolizumab in unresectable hepatocellular carcinoma: a phase 2 trial.
Hsiehchen D, Beg MS, Kainthla R, Lohrey J, Kazmi SM, Khosama L, Maxwell MC, Kline H, Katz C, Hassan A, Kubota N, Siglinsky E, Pillai AK, Youssoufian H, Mockbee C, Culm K, Uhlik M, Benjamin L, Brekken RA, Ahn C, Singal AG, Zhu H, Hoshida Y, Yopp AC. Hsiehchen D, et al. Among authors: kazmi sm. Nat Commun. 2024 Mar 11;15(1):2178. doi: 10.1038/s41467-024-46542-y. Nat Commun. 2024. PMID: 38467639 Free PMC article. Clinical Trial.
Immune Checkpoint Inhibitors in pMMR/MSS Colorectal Cancer.
El Hajj J, Reddy S, Verma N, Huang EH, Kazmi SM. El Hajj J, et al. Among authors: kazmi sm. J Gastrointest Cancer. 2023 Dec;54(4):1017-1030. doi: 10.1007/s12029-023-00927-2. Epub 2023 Apr 3. J Gastrointest Cancer. 2023. PMID: 37009977 Review.
Characteristics and clinical outcomes in young-onset cholangiocarcinoma.
Reddy S, Goksu SY, Sanford NN, Kainthla R, Hsiehchen D, Sanjeevaiah A, Jones AL, Karagkounis G, Al Mutar S, Ahn C, Beg MS, Kazmi SM. Reddy S, et al. Among authors: kazmi sm. Cancer Med. 2023 Jul;12(13):14094-14103. doi: 10.1002/cam4.6063. Epub 2023 May 22. Cancer Med. 2023. PMID: 37212509 Free PMC article.
Trends in Adjuvant Chemotherapy Use Among Stage III Colon Cancer in Non-Elderly and Low Comorbidity Patients.
El Hajj J, Soleja M, Goksu SY, Ahn C, Sanford NN, Karagkounis G, Pogacnik JS, Ali F, Chilakamarry S, Kainthla R, Hsiehchen D, Jones AL, Al Mutar S, Sanjeevaiah A, Beg MS, Huang EH, Kazmi SM. El Hajj J, et al. Among authors: kazmi sm. Clin Colorectal Cancer. 2022 Dec;21(4):315-324. doi: 10.1016/j.clcc.2022.09.001. Epub 2022 Sep 17. Clin Colorectal Cancer. 2022. PMID: 36283915
592 results